Sensitive troponin assay and the classification of myocardial infarction
- PMID: 25436428
- PMCID: PMC4414368
- DOI: 10.1016/j.amjmed.2014.10.056
Sensitive troponin assay and the classification of myocardial infarction
Abstract
Background: Lowering the diagnostic threshold for troponin is controversial because it may disproportionately increase the diagnosis of myocardial infarction in patients without acute coronary syndrome. We assessed the impact of lowering the diagnostic threshold of troponin on the incidence, management, and outcome of patients with type 2 myocardial infarction or myocardial injury.
Methods: Consecutive patients with elevated plasma troponin I concentrations (≥50 ng/L; n = 2929) were classified with type 1 (50%) myocardial infarction, type 2 myocardial infarction or myocardial injury (48%), and type 3 to 5 myocardial infarction (2%) before and after lowering the diagnostic threshold from 200 to 50 ng/L with a sensitive assay. Event-free survival from death and recurrent myocardial infarction was recorded at 1 year.
Results: Lowering the threshold increased the diagnosis of type 2 myocardial infarction or myocardial injury more than type 1 myocardial infarction (672 vs 257 additional patients, P < .001). Patients with myocardial injury or type 2 myocardial infarction were at higher risk of death compared with those with type 1 myocardial infarction (37% vs 16%; relative risk [RR], 2.31; 95% confidence interval [CI], 1.98-2.69) but had fewer recurrent myocardial infarctions (4% vs 12%; RR, 0.35; 95% CI, 0.26-0.49). In patients with troponin concentrations 50 to 199 ng/L, lowering the diagnostic threshold was associated with increased healthcare resource use (P < .05) that reduced recurrent myocardial infarction and death for patients with type 1 myocardial infarction (31% vs 20%; RR, 0.64; 95% CI, 0.41-0.99), but not type 2 myocardial infarction or myocardial injury (36% vs 33%; RR, 0.93; 95% CI, 0.75-1.15).
Conclusions: After implementation of a sensitive troponin assay, the incidence of type 2 myocardial infarction or myocardial injury disproportionately increased and is now as frequent as type 1 myocardial infarction. Outcomes of patients with type 2 myocardial infarction or myocardial injury are poor and do not seem to be modifiable after reclassification despite substantial increases in healthcare resource use.
Keywords: Myocardial infarction; Outcomes; Troponin; Type 2.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome.JAMA. 2011 Mar 23;305(12):1210-6. doi: 10.1001/jama.2011.338. JAMA. 2011. PMID: 21427373
-
Implications of lowering threshold of plasma troponin concentration in diagnosis of myocardial infarction: cohort study.BMJ. 2012 Mar 15;344:e1533. doi: 10.1136/bmj.e1533. BMJ. 2012. PMID: 22422871 Free PMC article.
-
Type 1 and 2 Myocardial Infarction and Myocardial Injury: Clinical Transition to High-Sensitivity Cardiac Troponin I.Am J Med. 2017 Dec;130(12):1431-1439.e4. doi: 10.1016/j.amjmed.2017.05.049. Epub 2017 Jul 21. Am J Med. 2017. PMID: 28739197
-
Assessment and classification of patients with myocardial injury and infarction in clinical practice.Heart. 2017 Jan 1;103(1):10-18. doi: 10.1136/heartjnl-2016-309530. Epub 2016 Nov 2. Heart. 2017. PMID: 27806987 Free PMC article. Review.
-
A Proposal for Modest Revision of the Definition of Type 1 and Type 2 Myocardial Infarction.Circulation. 2019 Nov 26;140(22):1773-1775. doi: 10.1161/CIRCULATIONAHA.119.042157. Epub 2019 Sep 6. Circulation. 2019. PMID: 31765259 Free PMC article. Review. No abstract available.
Cited by
-
Takotsubo Syndrome: The Secret Crosstalk between Heart and Brain.Rev Cardiovasc Med. 2023 Jan 10;24(1):19. doi: 10.31083/j.rcm2401019. eCollection 2023 Jan. Rev Cardiovasc Med. 2023. PMID: 39076872 Free PMC article. Review.
-
Altered Arterial Stiffness, Ventricular-Arterial Coupling and Troponin Levels in Patients with Systemic Lupus Erythematosus.Medicina (Kaunas). 2024 May 16;60(5):821. doi: 10.3390/medicina60050821. Medicina (Kaunas). 2024. PMID: 38793004 Free PMC article.
-
Characterization of Myocardial Injury With High-Sensitivity Troponin.Tex Heart Inst J. 2023 Dec 18;50(6):e238108. doi: 10.14503/THIJ-23-8108. Tex Heart Inst J. 2023. PMID: 38115713 Free PMC article.
-
Implementation of a high sensitivity cardiac troponin I assay and risk of myocardial infarction or death at five years: observational analysis of a stepped wedge, cluster randomised controlled trial.BMJ. 2023 Nov 27;383:e075009. doi: 10.1136/bmj-2023-075009. BMJ. 2023. PMID: 38011922 Free PMC article. Clinical Trial.
-
Elevated Cardiac Troponin Is Most Often Associated With Type 2 Myocardial Infarction in Trauma Patients.Cureus. 2023 May 30;15(5):e39711. doi: 10.7759/cureus.39711. eCollection 2023 May. Cureus. 2023. PMID: 37398763 Free PMC article.
References
-
- Thygesen K., Alpert J.S., Jaffe A.S. Third universal definition of myocardial infarction. Eur Heart J. 2012;33:2551–2567. - PubMed
-
- Morrow D.A., Wiviott S.D., White H.D. Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction. Circulation. 2009;119:2758–2764. - PubMed
-
- Bonaca M.P., Wiviott S.D., Braunwald E. American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial. Circulation. 2012;125:577–583. - PubMed
-
- White H.D., Reynolds H.R., Carvalho A.C. Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: Results from long-term follow-up of the occluded artery trial (OAT) cohort. Am Heart J. 2012;163:563–571. - PMC - PubMed
-
- Alpert J.S., Thygesen K.A., White H.D., Jaffe A.S. Diagnostic and therapeutic implications of type 2 myocardial infarction: review and commentary. Am J Med. 2014;127:105–108. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous